These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9661036)

  • 21. In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem.
    Sakagawa E; Otsuki M; Oh T; Nishino T
    J Antimicrob Chemother; 1998 Oct; 42(4):427-37. PubMed ID: 9818740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of the new quinolone WCK 771 against pneumococci.
    Appelbaum PC; Pankuch GA; Bozdogan B; Lin G; Jacobs MR; Patel MV; Gupte SV; Jafri MA; De Souza NJ; Khorakiwala HF
    Clin Microbiol Infect; 2005 Jan; 11(1):9-14. PubMed ID: 15649298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of hinokitiol against both antibiotic-resistant and -susceptible pathogenic bacteria that predominate in the oral cavity and upper airways.
    Domon H; Hiyoshi T; Maekawa T; Yonezawa D; Tamura H; Kawabata S; Yanagihara K; Kimura O; Kunitomo E; Terao Y
    Microbiol Immunol; 2019 Jun; 63(6):213-222. PubMed ID: 31106894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FCE 22101 and FCE 22891: in-vitro antibacterial activity at concentrations simulating human plasma levels following intravenous, intramuscular and oral administration.
    Della Bruna C; Jabes D; Rossi R; Younes G; Castellani P
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():119-28. PubMed ID: 2659570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models.
    Abdelraouf K; Nicolau DP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo antibacterial activity of FK482, a new orally active cephalosporin.
    Mine Y; Yokota Y; Wakai Y; Kamimura T; Tawara S; Shibayama F; Kikuchi H; Kuwahara S
    J Antibiot (Tokyo); 1988 Dec; 41(12):1888-95. PubMed ID: 3209480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Wakai Y; Kamimura T; Tawara S; Matsumoto S; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):88-98. PubMed ID: 8436563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study to determine the pharmacokinetics and inflammatory fluid penetration of two doses of a solid formulation of the hexetil prodrug of a trinem, sanfetrinem (GV 104326).
    Wise R; Andrews JM; Da Ros L; Child J; Mortiboy D
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1761-4. PubMed ID: 9257756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo pharmacokinetic/pharmacodynamic activity of clofoctol.
    Scaglione F; Dugnani S; Lucini V; Pannacci M; Paraboni L
    J Chemother; 2012 Aug; 24(4):201-6. PubMed ID: 23040683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia.
    Murakami K; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 2000 Oct; 46(4):629-32. PubMed ID: 11020264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
    Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.
    Li GQ; Bai XG; Li CR; Yang XY; Hu XX; Yuan M; Zhang WX; Lou RH; Guo HY; Jiang JD; You XF
    J Antimicrob Chemother; 2012 Apr; 67(4):955-61. PubMed ID: 22210757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis.
    Guérin-Faublée V; Carret G; Houffschmitt P
    Vet Rec; 2003 Apr; 152(15):466-71. PubMed ID: 12723630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sanfetrinem, the member of trinems--in vitro activity against Klebsiella pneumoniae producing ESBL].
    Wieczorek P; Sacha PT; Leszczyńska K; Jakoniuk P; Zalewska M
    Med Dosw Mikrobiol; 2006; 58(1):27-32. PubMed ID: 16871970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
    Hikida M; Itahashi K; Igarashi A; Shiba T; Kitamura M
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2010-6. PubMed ID: 10428928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, Synthesis, and Biological Evaluation of Novel 7-[(3 aS,7 aS)-3 a-Aminohexahydropyrano[3,4- c]pyrrol-2(3 H)-yl]-8-methoxyquinolines with Potent Antibacterial Activity against Respiratory Pathogens.
    Odagiri T; Inagaki H; Nagamochi M; Kitamura T; Komoriya S; Takahashi H
    J Med Chem; 2018 Aug; 61(16):7234-7244. PubMed ID: 30063826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.